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Proteomic characterization of 
neuromelanin granules isolated 
from human substantia nigra by 
laser-microdissection
Sarah Plum1, Simone Steinbach1, Johannes Attems2, Sharon Keers2, Peter Riederer3, 
Manfred Gerlach4, Caroline May1,* & Katrin Marcus1,*
Neuromelanin is a complex polymer pigment found primarily in the dopaminergic neurons of human 
substantia nigra. Neuromelanin pigment is stored in granules including a protein matrix and lipid 
droplets. Neuromelanin granules are yet only partially characterised regarding their structure and 
function. To clarify the exact function of neuromelanin granules in humans, their enrichment and in-
depth characterization from human substantia nigra is necessary. Previously published global proteome 
studies of neuromelanin granules in human substantia nigra required high tissue amounts. Due to the 
limited availability of human brain tissue we established a new method based on laser microdissection 
combined with mass spectrometry for the isolation and analysis of neuromelanin granules. With this 
method it is possible for the first time to isolate a sufficient amount of neuromelanin granules for global 
proteomics analysis from ten 10 μm tissue sections. In total 1,000 proteins were identified associated 
with neuromelanin granules. More than 68% of those proteins were also identified in previously 
performed studies. Our results confirm and further extend previously described findings, supporting the 
connection of neuromelanin granules to iron homeostasis and lysosomes or endosomes. Hence, this 
method is suitable for the donor specific enrichment and proteomic analysis of neuromelanin granules.
Neuromelanin (NM) is a black-brownish pigment that mainly accumulates in dopaminergic neurons in the sub-
stantia nigra pars compacta (SNpc). In these dopaminergic neurons NM is associated with a protein matrix as 
well as lipid droplets and stored in intracellular granules1. So far NM granules cannot be identified in human 
newborns, but seem to start forming in childhood presumably from the age of three years. From then on an 
increase in amount and density of NM granules can be observed during normal aging2,3. The physiological func-
tion of NM granules is controversial discussed in literature. Besides an involvement of NM granules in cell iron 
homeostasis, a neuroprotective function by sequestration of toxic substances e.g. of environmental chemicals 
and metals or byproducts of dopamine synthesis is postulated4,5. Diametrically oppose neurotoxic effects of NM 
through production of oxygen and nitrogen species6,7 as well as microglia or dendritic cell activation8–10 have been 
discussed due to the fact that especially NM granules containing neurons are prone to the selective degeneration 
in Parkinson’s disease5,11. A specificity of NM granules is, that they do not form in common laboratory animals 
like mice12. Therefore, the described hypotheses about the function of NM granules in humans are based on 
experiments in cell culture and animals exposed to synthetic NM pigment or isolated human NM pigment6–10.
In order to understand the function of NM granules in human individuals, in-depth characterization of the 
NM granule content derived directly from human brain tissue is needed. Previous analyses of SNpc tissue in 
the context of Parkinson’s disease have predominately involved whole tissue lysates13 because the enrichment of 
sub-fractions or even subcellular fractions, such as NM granules, often requires larger quantities of human brain 
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tissue than the amounts available. However, analysis of subcellular entities permits the identification of proteins 
that are less abundant and enables a more focused view of NM granules-related processes. Our group has previ-
ously developed methods based on density-gradient centrifugation with reduced tissue requirements to enrich 
NM granules, as well as synaptosomes for proteomic analysis14. Mass spectrometric analysis of those enriched 
NM granules led to the identification of NM granules specific proteins for the first time. Based on our proteomic 
data we hypothesized the generation of NM granules to resemble lysosome formation1. A limiting factor of those 
studies was obtaining sufficient numbers of individual high quality SNpc samples in required amounts (0.15 g, 
at least a half SNpc) to perform one experiment14. Due to this, only studies with small sample sizes could be per-
formed which reduces statistical power of the experimental approach.
In order to overcome these limitations, laser microdissection (LMD) was optimized using thin sections of 
human substantia nigra (SN) tissue. Those are common in pathological studies and thus more readily available. In 
this paper, we present the successful application of LMD to isolate NM granules and their subsequent character-
ization using proteomic analysis. This enables a substantial reduction of the required tissue amounts and allows 
further insights regarding NM granules development and function.
Materials and Methods
Ethics statement. The use of human post mortem brain tissue was approved by the ethics committees of 
the Ruhr-University Bochum, Germany (file number 4760-13) and the University of Würzburg, Germany (file 
number 78/99) accordance with German guidelines and regulations. In case of tissue from the Netherlands Brain 
Bank, all material has been collected from donors for or from whom a written informed consent for a brain 
autopsy and the use of the material and clinical information for research purposes had been obtained by the 
Netherlands Brain Bank. Tissue from the Newcastle Brain Tissue Resource was obtained in accordance with the 
approval of the joint Ethics Committee of Newcastle, United Kingdom, and North Tyneside Health Authority, 
United Kingdom, with written informed consent and following Newcastle Brain Tissue Resource brain banking 
procedures.
Subjects. Cryopreserved postmortem SN sections from five human subjects with no history of neurological or 
neurodegenerative diseases and lacking neuropathological abnormalities were provided by the Brain Bank Center 
Würzburg, the Newcastle Brain Tissue Resource, UK and the Netherlands Brain Bank, Netherlands Institute for 
Neuroscience, Amsterdam. Neuropathological diagnoses were assigned using accepted international neuropatho-
logical criteria including neuritic Braak stages, Thal amyloid phases, CERAD scores, NIA-AA scores and McKeith 
criteria.
Cryosectioning for laser microdissection. The frozen midbrains were stored at − 80 °C and sec-
tioned at the level of the SN, which can be clearly identified by its dark color15. With a Microm HM550 cryostat 
(Thermo Scientific, Dreieich, Germany) combined with a fixed knife holder (Leica Biosystems, Nußloch GmbH, 
Nußloch, Germany), slices were cut at − 18 °C object temperature and − 20 °C chamber temperature. The 5, 10 
or 20 μm thick sections were placed on 1.0 PEN membrane glass slides that were optimized for LMD (Carl Zeiss 
Microscopy GmbH, Göttingen, Germany).
Sampling using laser microdissection. Using the bright field microscope of LMD (PALM Micro Beam, 
P.A.L.M.-System, Carl Zeiss Microscopy GmbH) NM granules can be observed within the SNpc without staining 
because of their black-brownish color. First, under bright field microscopy, the tissue slices were screened for NM 
granules at 400x magnification, and these granules were marked using software supplied by the manufacturer 
(PALMRobo 4.6 pro, Carl Zeiss Microscopy GmbH). Once all NM granules in a tissue section were marked, a 
non-adhesive microtube cap (MicroTube 500, Carl Zeiss Microscopy GmbH) filled with 50 μ L of distilled water 
was applied to the instrument and placed over the tissue slice. First, NM granules were cut and catapulted with 
a laser into the sample cap. Afterwards, the tube was carefully closed and stored at − 80 °C until further usage. 
Tissue depleted of NM granules was collected as control in a fresh tube as contamination control and treated like 
the NM granules samples (further referred to as “control”).
Proteomic analysis using mass spectrometry. Prior to tryptic digestion, the NM granules and control 
samples were adjusted with 2% (w/v) RapiGest™ SF Surfactant (Waters GmbH, Milford, MA, USA) to a final con-
centration of 0.1% RapiGest™ . After incubation in an ultrasonic bath for 1 min, the samples were briefly centri-
fuged. The digestion protocol was performed as previously described15. Briefly, 250 mM dithiothreitol was added 
and the samples were incubated for 30 min at 60 °C. Then, 0.55 M iodoacetamide was added and the samples were 
incubated for another 30 min in the dark. Trypsin was diluted in 50 mM ammonium bicarbonate and was added 
1:25 (v/v) to the samples. Subsequently, digestion was performed for 4 h at 37 °C. The reaction was stopped via 
the addition of 10% trifluoroacetic acid (TFA) and incubation for 30 min at 37 °C. After 15 min centrifugation at 
20,800 × g(av), the supernatant was transferred to a new sample vial and completely dried in a SpeedDry vacuum 
concentrator (RVC 2-25 CDplus, Martin Christ Gefriertrocknungsanlagen GmbH, Osterode, Germany). The 
peptides were stored in 20 μ L of 0.1% TFA and maintained at − 80 °C until the mass spectrometric measure-
ments could be performed. The peptide concentrations were determined via amino acid analysis as previously 
described14. Liquid chromatography tandem mass spectrometry (LC-MS/MS) analyses were performed with 
200 ng of the sample per run using an UltiMate 3000 RSLC nano LC system (Dionex, Idstein, Germany) coupled 
to an Orbitrap Elite mass spectrometer (Thermo Fisher Scientific, Bremen, Germany). Moreover, equal amounts 
of each sample were taken to prepare a mixture, which was measured in between the samples allowing analyzation 
of technical variances during measurements.
The peptides were first loaded on a capillary pre-column (Dionex, 100 μ m × 2 cm, particle size 5 μ m, pore size 
100 Å) and washed for 7 min with 0.1% TFA. The pre-column was subsequently connected with an analytical 
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C18 column (Dionex, 75 μ m × 50 cm, particle size 2 μ m, pore size 100 Å). Peptide separation was performed with 
400 nL/min flow rate with a gradient that was initiated with 95% A (0.1% formic acid) and 5% B (84% acetonitrile, 
0.1% formic acid) with increasing amounts of B (up to 40% within 95 min). The concentration of B was then 
increased to 95% within 2 min and maintained for 3 min. Afterwards, the column was again adjusted to 5% B. 
The LC system was directly coupled with a nano electrospray ionization source (Thermo Fisher Scientific) to the 
Orbitrap Elite mass spectrometer. The system operated with a scan range from 300 to 2,000 m/z with a resolution 
of 30,000 and 500 ms maximum acquisition time. From each full scan, the 20 most intensive ions were selected for 
low-energy collision induced dissociation (CID) with 35% collision energy and 50 ms maximal acquisition time. 
After fragment ion (MS/MS) scans, the mass to charge (m/z) values of the precursor masses were maintained for 
35 s on a dynamic exclusion list. The mass spectrometry raw data have been deposited to the ProteomeXchange 
Consortium via the PRIDE16 partner repository with the dataset identifier PXD004987 and 10.6019/PXD004987.
Data analysis. Raw files derived from the measurements were analyzed using Proteome Discoverer 1.4 
(Thermo Fisher Scientific, Bremen, Germany). For these analyses, a workflow template was designed using the 
Mascot search algorithm (Matrix Science, London, UK, version 2.2.0) for protein identification. The peptide mass 
tolerance was set to 5 ppm, and the fragment mass tolerance was 0.4 Da. The enzyme settings were set to “trypsin” 
and one possible missed cleavage site. Methionine oxidation was set as a variable modification and carbami-
domethylation at cysteine was set as fixed modification. All data were searched against the UniProt/SwissProt 
decoy database (release 2015_05 of 29.04.2015; 548,454 entries without decoys) with a restriction to “Homo sapi-
ens”. Resulting files were deposited along with the raw files to the ProteomeXchange Consortium via the PRIDE16 
partner repository with the dataset identifier PXD004987 and 10.6019/PXD004987.
The spectral index calculations were subsequently performed as described17,18. To reduce false-positive iden-
tifications the false discovery rate (FDR) was set on peptide spectrum match (PSM) level to < 0.01, the PSM were 
exported from PIA (https://github.com/mpc-bioinformatics/pia) and further processed using the “pivot table” 
function in Microsoft Excel, which yielded a table of the spectral counts for every peptide that belonged to a cer-
tain protein in a sample. Here, only peptides assigned to be unique by PIA were used for protein identification and 
further relative quantification. Using this strategy, no decoy entries were left, hence protein level FDR was 0. The 
resulting protein table was then filtered, and only proteins identified in at least four of five NM granules or in three 
of four control samples with a t-test p-value < 0.05 and a significant fold change were accepted for subsequent 
analysis. For this, technical variance was estimated by analyzing mixture measurements with spectral counting as 
described above. Proteins identified in at least two of six measurements were used to calculate technical variances 
by dividing the mean of the spectral indices through the standard deviation. The mean of the protein specific 
variation coefficients was 0.2644 and was multiplied with 4 to estimate which fold change would be accounted as 
differential by biological means and not differential due to technical variance. The resulting fold change cut off 
value was 1.058.
Subsequently, the list of proteins overrepresented in NM granules compared to the control (t-test< 0.05; fold 
change < 1.058) was analyzed using Ingenuity® pathway analysis (http://www.ingenuity.com, Qiagen, Redwood 
City, CA 94063, USA) to roughly determine their function and localization. Ingenuity® pathway analysis is a 
web-based software application for the analysis, integration, and interpretation of data. Proteins were uploaded 
to assign localization and function basing on a knowledge base implemented in the software.
Identified proteins were also compared with proteins identified from NM granules enriched by density gra-
dients1,14,19. Moreover, the proteins were further characterized regarding their function and localization via the 
analysis of Gene Ontology data deposited at www.uniprot.org and via functional annotation clustering using 
DAVID20,21.
Additionally, resulting p-values were adjusted using R according to the method of Benjamini and Hochberg to 
control the false discovery rate of the t-test and identify highly significant differential proteins22,23.
The resulting data are shown in Supplement Table 1.
Results
Established laser microdissection settings for neuromelanin granules isolation. First, the 
parameters for NM granules isolation were tested using postmortem tissues from human donors without neu-
rological or neurodegenerative diseases and lacking neuropathological abnormalities. In order to evaluate the 
optimal parameters for laser microdissection, 5, 10 and 20 μ m thick sections were mounted on PEN membrane 
slides. Further staining was omitted because the NM granules are naturally black-brownish colored and standard 
histological staining methods might have an effect on subsequent proteomic analysis24,25. Figure 1 shows SN 
tissue at 200x (A) and 400x (B–D) magnification. Using 200x magnification (A), it was possible to identify NM 
granules, cut 5, 10 and 20 μ m thick sections and catapult NM granules into the micro tube lid. The analysis at 400x 
magnification of the fractions cut at 200x magnification indicated that regions marked for isolation may have also 
included neuronal tissue other than NM granules. Thus, 400x magnification was chosen for cutting to reduce 
contamination by surrounding tissue, but with these settings it was not possible to cut 20 μ m thick sections. In 
the following experiments, NM granules were enriched from 10 μ m thick SN slices using 400x magnification.
Identified proteins from neuromelanin granules derived by laser microdissection. To ensure 
that sufficient material was available for LC-MS/MS analysis, at least 550,000 μ m2 of NM granules were collected 
from an average of six 10 μ m SN sections of each tested tissue. After tryptic digestion of NM granule proteins, 
the peptide concentration was estimated to be between 0.04 and 0.07 μ g/μ l. LC-MS/MS measurements and data 
analysis were performed resulting in the identification of 214 significantly differential proteins (t-test p-value 
< 0.05) in NM granules compared to control. Of these, 48 were underrepresented and 166 proteins were overrep-
resented in NM granules.
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To further analyze the quality of our LMD based enrichment strategy, the identified proteins were compared 
with published data1,19. 50 of the 73 proteins identified by Tribl et al. in NM granules enriched using sucrose and 
Percoll® density gradients1 were identified in at least four of five LMD processed NM granules samples indicating 
an overlap of 68%. 17 of these proteins (23%) were significantly overrepresented in NM granules in comparison 
to control. We additionally compared proteins identified in the study published by Plum and co-workers in 2013 
based on density gradient centrifugation14. Here, we identified 277 proteins related to NM granules, of which 203 
(73%) proteins were also identified in at least four of five LMD-enriched NM granules, 32 of these proteins were 
significantly overrepresented in NM granules compared to control. As most of the previously identified NM gran-
ules related proteins could be identified with our approach, it is reasonable to conclude that laser microdissection 
is an optimally suited enrichment method for NM granule.
Functional and biological character of proteins identified in neuromelanin granules. The cel-
lular distributions and functions of the 166 significantly overrepresented proteins in NM granule samples using 
Ingenuity® pathway (http://www.ingenuity.com) revealed the following: 70% of these proteins are cytoplasmic 
proteins, followed by proteins associated with nuclei (15.7%; Fig. 2A). In terms of function 33% of the proteins are 
known to have enzymatic functions and 8.4% of the proteins are transporters (Fig. 2B).
In-depth analysis of our data indicated iron binding proteins in NM granules, such as sideroflexin-1 or sero-
transferrin, being significantly (p-value < 0.05) overrepresented in NM granules. Ferritin light chain previously 
described to be a component of NM granules19 as well as heavy chains were identified but with a t-test p-value 
> 0.05. Interestingly, both alpha- and beta-synuclein were identified unequivocally significantly overrepresented 
in NM granules. Additionally, proteins related to lysosomes or endosomes such as lysosomal alpha-glucosidase, 
sialate O-acetylesterase, mammalian ependymin-related protein 1, dipeptidyl peptidase II, Cathepsin (B, D and 
Z), syntaxin 8 or serotransferrin showed higher abundance in NM granules.
19 proteins significantly overrepresented in NM granules are associated with lysosomes (DAVID p-value 5.89 e−11, 
cluster 4 enrichment score 4.35), hence supporting the hypothetical link between lysosomes and NM granules as 
previously hypothesized1.
Besides, 20 proteins were related to the Golgi complex (DAVID p-value 0.0075, cluster 9 enrichment score 
1.66) and 25 proteins were found to be associated with the endoplasmic reticulum (DAVID p-value 3.99 e−4, 
cluster 5 enrichment score 2.67).
The origin of NM pigment is not clear so far. The pigment is believed to originate from the tyrosinase-catalyzed 
oxidation of dopamine similar to the melanin synthesis in the skin26–29. Therefore, we specifically searched our data 
Figure 1. Substantia nigra tissue mounted on a PEN membrane slide at (A) 200x magnification and (B–D) 
400x magnification. Neuromelanin granules (examples indicated by arrows) can be identified as black-brownish 
structures. (C) shows the tissues with marked neuromelanin granules (yellow line) for the LMD and (D) after 
cutting and catapulting neuromelanin granules in a tube cap. Scale bars in A = 150 μ m and B–D = 75 μ m.
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for enzymes being involved in this pathway. In accordance with immunohistochemical and Western blot analysis 
of the human SN30,31 tyrosinase could not be identified in our study; neither in the NM granules nor in the con-
trol. Instead, tyrosine hydroxylase which catalyzes the reaction from L-tyrosine to L-3,4-dihydroxyphenylalanine 
(L-DOPA) was identified unambiguously: it seems to be more than twofold overrepresented in NM granules, 
but the results were not significant (t-test p = 0.226) in our preliminary study with only 5 individual samples. 
Dopa decarboxylase, which inter alia catalyzes the decarboxylation of L-DOPA to dopamine, was detected sig-
nificantly (t-test p-value = 0.029) and more than eight times overrepresented in NM granules. Furthermore, a 
protein important for dopamine degradation, amine oxidase A (MAO-A) was identified in NM granules but there 
was no significant difference besides it seemed slightly underrepresented compared to control (fold change -1.3, 
t-test p-value 0.56).
Discussion
Here, we present a new strategy to isolate NM granules from cryopreserved postmortem SN sections from human 
subjects with no history of neurological or neurodegenerative diseases and lacking neuropathological abnormal-
ities. The approach was successfully applied by using LMD and subsequent LC-MS/MS analysis for proteome 
analysis and will in future permit further in-depth characterization of NM granules from both neuropatholog-
ical healthy donors as well as patients suffering from neurodegenerative diseases. Furthermore, LMD allows 
the enrichment of other cellular or subcellular structures such as neurons15, Lewy bodies32,33 or amyloid beta 
plaques34. Thus, it can be thought of combining different protocols to co-enrich e.g. NM granules and Lewy bod-
ies from the same tissue.
Compared to previous enrichment protocols, which were applicable to at least 0.15 g tissue14, the LMD based 
enrichment strategy presented in this paper allows to use much lower amounts of tissue. As thin tissue sections 
were used, total amounts of tissue can only be estimated. In average tissue slices were 2 × 1 cm in size and tissue 
was sliced to 10 μ m thickness. This results in a volume of 0.002 cm3. Brain tissue density has been described to 
be about 1.04 g/cm3 35. A maximum of 8 thin sections were used to obtain sufficient amounts of neuromelanin 
granules, hence roughly up to 16.6 mg tissue was used compared to at least 150 mg up to 1 g brain tissue used a 
priori1,14.
We used LC-MS/MS to identify proteins associated with NM granules to easily compare the enrichment data 
with our previously published data1,14,19. However, the presented method could also be combined with other ana-
lytical strategies, such as anti-melanin ELISA36, e.g., combined with a second ELISA to analyze whether specific 
proteins are attached to the NM granules.
The overlap of identified proteins compared to previously published data was between 68% and 73%. 
Remaining differences could be due to technical variances, resulting from different enrichment methods (den-
sity gradient based versus LMD) as well as alterations in the measurement systems. E.g. Tribl et al. used an ion 
trap mass spectrometer several years ago with less resolution, accuracy and sensitivity compared to the orbitrap 
system used in the presented work1. However, it is more likely, that the reported differences reflect biological 
variances, as tissues from different human donors were used in the different studies varying e.g. in country of 
origin, age or gender. This hypothesis needs to be verified in future studies with higher case numbers. Anyhow, 
the protein overlap between this study and former studies of Tribl et al. as well as Plum et al. was satisfactory, 
clearly demonstrating the applicability of this new established LMD-based enrichment method. We identified 
many of the previously reported NM granules associated proteins e.g. both ferritin light and heavy chain as well 
as sideroflexin-1 indicating a connection of NM granules to iron ion homeostasis.
In addition to NM pigment, NM granules consist of approximately 15% amino acids and approximately 
20% lipids4. Assuming, that the protein content is a result of protein sequestration during NM synthesis, the 
Figure 2. Diagrams showing the distribution of proteins overrepresented in neuromelanin granules compared 
to control according to their localization (A) or function (B). A large number of neuromelanin granule-
associated proteins are assigned to the cytoplasm. Furthermore, 33% of the proteins have enzymatic functions 
and 8.4% are transporters.
www.nature.com/scientificreports/
6Scientific RepoRts | 6:37139 | DOI: 10.1038/srep37139
characterization of proteins contained in NM granules provides insights regarding NM development. The anal-
ysis revealed 166 proteins significantly overrepresented in NM granules compared to control. By utilization of 
the Gene Ontology annotations 19 proteins of the differentially expressed proteins could be related to lysosomes, 
which underlines the lysosomal relationship of NM granule which was already previously described37. Previously 
knowledge2,3 combined with these new findings lead to the hypothetical process describing NM granules genesis 
depicted in Fig. 3.
After formation, NM could subsequently be macro-phagocytized and packed in endosomes or lysosomes for 
degradation. Since NM is non-degradable aggregation in endosomes or lysosomes is likely. Fusion of NM con-
taining endosomes might finally result in growing NM granules surrounded by a double membrane and might 
explain age depending NM granules formation (1,8). Furthermore, an assumed fusion of NM granules with 
endolysosomes might explain identification of mitochondrial related proteins in NM granules.
Summary and Outlook
Due to the fact that SN tissue is very valuable and challenging to obtain, the presented LMD strategy offers a 
major advantage compared with other NM granules enrichment strategies, because only a few thin tissue sections 
are required instead of an entire SN. Future studies could therefore investigate for the first time higher case num-
bers from healthy donors for obtaining a better statistical significance and deeper insights into the biological var-
iance, including ethical variations. Moreover, analysis of different age groups could lead to deeper insights in NM 
granules genesis and function. Besides, NM granules from cases with neurodegenerative diseases e.g. Parkinson’s 
disease could be analyzed. Further, other cellular or subcellular structures such as neurons15 or Lewy bodies32,33 
could be enriched from the same tissue slices allowing a thorough analysis.
Performing differential studies comparing proteins isolated from human subjects with no history of neuro-
logical or neurodegenerative diseases and lacking neuropathological abnormalities and subjects with neurode-
generative diseases could lead to a better understanding of the role of NM granules during neurodegeneration.
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